New Medicines of 2015
Toujeo is a prescription drug used to treat both type 1 and type 2 diabetes. Toujeo, a long-acting form of insulin, works by replacing the insulin that is normally produced by the body and by helping the body use sugar for energy. It also stops the liver from producing more sugar. This medication comes in an injectable, prefilled pen to be injected under the skin. Toujeo is usually injected once a day. Common side effects include low blood sugar, weight gain, and redness and skin thickening at the injection site. Toujeo is another treatment option for patients who need a longer-acting insulin. It lasts a few hours longer than Lantus, another long-acting insulin treatment.
Reviewed by:
Review Date:
December 29, 2015Citation:
U.S. Food and Drug Administration, "FDA approves first-of-its-kind product for the treatment of melanoma", 2015 U.S. Food and Drug Administration, "FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa", 2015 U.S. Food and Drug Administration, "FDA approves Ninlaro, new oral medication to treat multiple myeloma", 2015 U.S. Food and Drug Administration, "FDA approves new treatment for HIV", 2015 U.S. Food and Drug Administration, "FDA approves Nucala to treat severe asthma", 2015 U.S. Food and Drug Administration, "FDA approves new treatment for advanced pancreatic cancer", 2015 U.S. Food and Drug Administration, "FDA approves first treatment for sexual desire disorder", 2015 U.S. Food and Drug Administration, "FDA approves new drug to treat heart failure", 2015 U.S. Food and Drug Administration, "FDA approves Praluent to treat certain patients with high cholesterol", 2015 U.S. Food and Drug Administration, "FDA approves Corlanor to treat heart failure", 2015 All images appear courtesy of Dreamstime
Last Updated:
December 29, 2015